¿¬Çõ

1995

ù¹ø° Ç÷°ü¼ºÇü¼ú ÇÐȸ(Angioplasty Summit)°¡ ¼­¿ï¾Æ»êº´¿øÀÇ ´ë°­´ç¿¡¼­ °³ÃֵǾú½À´Ï´Ù.

1997

¹Ì±¹ Cardiovascular Research Foundation (CRF)ÀÇ Chief Medical OfficialÀÎ °Ô¸® ¹ÎÃ÷°¡ Á¶Á÷À§¿øȸ¿¡ Âü¿©ÇÏ¿´½À´Ï´Ù.

2000

Çѱ¹¿¡¼­ ÃÖÃÊ·Î ¹Ì±¹ TCTÇÐȸ¿¡ °æÇÇÀû ÁßÀç¼úÀ» À§¼º Áß°è·Î ¼ÛÃâÇÏ¿´½À´Ï´Ù.

2001

¸»ÃÊ Ç÷°ü ÁßÀ縦 Æ÷ÇÔÇÑ ½ÉÇ÷°ü¿¡ °ü·ÃµÈ Æø³ÐÀº ÁÖÁ¦µéÀÌ ´Ù·ïÁ³½À´Ï´Ù.

2002

½ÉÀåÇ÷°ü¿¬±¸Àç´Ü(CVRF)ÀÌ ¼³¸³µÇ¾ú°í, °ü»óµ¿¸Æ ÁßÀç½Ã¼ú ±¹Á¦ÇмúȸÀÇ(TCTAP)°¡ ½ÉÀåÇ÷°ü¿¬±¸Àç´ÜÀÇ Áö¿øÀ¸·Î ü°èÀûÀ¸·Î ¿î¿µµÇ±â ½ÃÀÛÇß½À´Ï´Ù.

2003

Àü¹®°¡ ±³À° ¹× Àü ¼¼°èÀÇ ¿¬±¸ÀÚ, ÀÇ·áÀÎ, ¾÷°è °£ÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °³¼±ÇÏ°íÀÚ ÇÏ´Â ¸ñÀûÀ¸·Î Summitmd.com¸¦ °³¼³ÇÏ¿´½À´Ï´Ù.

2004

¾à200¸íÀÇ ÆÑÄÃƼ¸¦ Æ÷ÇÔÇÑ Àü¼¼°è¿¡¼­ Âü¿©ÇÏ´Â 2,000¿©¸íÀÇ Âü°¡ÀÚµéÀ» ¼ö¿ëÇϱâ À§ÇÏ¿© ÇÐȸÀåÀ» ¼­¿ï ¿öÄ¿Èú ½¦¶óÅæ È£ÅÚ·Î È®Àå ÀÌÀüÇÏ¿´½À´Ï´Ù. äÅÃµÈ ÃÊ·ÏÀÌ International Journal of Cardiovascular Intervention (IJCI)ÀÇ Æ¯º°ÆÇÀ¸·Î ÃâÆǵǾú½À´Ï´Ù.

2005

10ÁÖ³âÀ» ¸ÂÀÌÇÏ¿© ¹Ì±¹ÀÇ Cardiovascular Research Foundation(CRF)¿ÍÀÇ °øµ¿ ÈÄ¿ø ÇÏ¿¡ ÇÐȸ¸íÀ» Angioplasty Summit-TCT Asia PacificÀ¸·Î º¯°æÇÏ¿´½À´Ï´Ù. EuroPCRÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÇØ¿Ü ±×·ìµéÀÌ Çмú ÇÁ·Î±×·¥ °³¹ß¿¡ Âü¿©Çϱ⠽ÃÀÛÇß½À´Ï´Ù. ÃÊ·ÏÀÌ American Journal of Cardiology (AJC)¿¡ ÃâÆǵǾú½À´Ï´Ù.

2008

µÎ¹ø° ÁÂÁÖ°£ºÎ¿Í ºÐÁö ÇÐȸ(Left Main and Bifurcation Summit)°¡ Á¦13ȸ Ç÷°ü¼ºÇü¼ú ÇÐȸ(Angioplasty Summit)¿Í ÇÔ²² ¿­·È½À´Ï´Ù.Endovascular Arena¿¡¼­ Ç÷°ü ºÐ¾ßÀÇ Èï¹Ì·Î¿î ÁÖÁ¦¿Í »õ·Î¿î ±â±â, ÀÓ»ó °á°ú¸¦ ´Ù·ç¾ú½À´Ï´Ù.

2010

ÇÐȸ¸íÀ» Ç÷°ü¼ºÇü¼ú °ü»óµ¿¸Æ ÁßÀç½Ã¼ú ±¹Á¦ÇмúȸÀÇ(ANGIOPLASTY SUMMIT-TCTAP)·Î º¯°æÇÏ¿´½À´Ï´Ù. ¾Õ¼­°¡´Â ÁßÀç ½ÉÀåÇÐ ÇÐȸ·Î¼­ Áõ°Å ±â¹Ý ½Ç½À¿¡ »Ñ¸®¸¦ µÐ FFR ¹× TAVI¿¡ ´ëÇÑ ½ÅÈï ºÐ¾ß¿Í °ü½Éµµ ³ôÀº ÁÖÁ¦°¡ ³íÀǵǾú½À´Ï´Ù.

2011

ȯÀÚ Ä¡·áÀÇ ±âº» ¿øÄ¢À» ÀÌÇØÇÏ°í Àû¿ëÇÏ¸ç °¢ ÁÖÁ¦¿¡ ´ëÇÑ ÃֽŠ°³³ä°ú Áö½ÄÀ» ¾ò¾î¾ß ÇÏ´Â Æç·Î¿ì, ÀþÀº ½ÉÀå Àü¹®ÀÇ ¹× ¸ðµç °Ç°­ °ü·Ã Àü¹®°¡¸¦ À§ÇØ TCTAP Fellowship Course°¡ ½ÃÀ۵Ǿú½À´Ï´Ù. ½ÉÇ÷°ü ÀÇÇÐ ºÐ¾ß¿Í TCTAPÀÇ ¼ºÀå¿¡ ÀÇ¹Ì ÀÖ´Â °øÇåÇÑ ºÐµé¿¡°Ô °¨»çÀÇ ¸¶À½À» ±â¸®±â À§ÇÑ ¸ñÀûÀ¸·Î Á¦1ȸ TCTAP ¡°Master of the Masters¡±°¡ ¼ö¿©µÇ¾ú½À´Ï´Ù.

2012

Partnership Session with Global Societies¿¡ ´õ ¸¹Àº ±Û·Î¹ú ÆÄÆ®³ÊµéÀÌ Âü¿©ÇÏ¿´½À´Ï´Ù. Çѱ¹¿¡¼­ óÀ½À¸·Î ½ÅÀå ½Å°æÂ÷´Ü¼ú ¹× °æÇÇÀû ´ëµ¿¸Æ ÆǸ· ġȯ¼ú (TAVI)ÀÇ ¶óÀÌºê ½Ã¿¬ÀÌ ¼öÇàµÇ¾ú½À´Ï´Ù.

2013

°­ÀÇ, »ç·Ê¿¬±¸, ¶óÀÌºê ½Ã¿¬À¸·Î ±¸¼ºµÈ CTO LIVE°¡ °³ÃֵǾú½À´Ï´Ù.

ÀþÀº ÀÓ»ó ¿¬±¸ÀÚµéÀ» µ¶·ÁÇϱâÀ§ÇØ TCTAP ÀþÀº °úÇÐÀÚ »ó¡±(Best Young Scientist Award)ÀÌ »õ·Ó°Ô â¼³µÇ¾ú½À´Ï´Ù.

2014

18°³±¹ 45°³ ±Û·Î¹ú ÆÄÆ®³Ê¿Í ÇÐȸµéÀÌ ÇÁ·Î±×·¥ ±¸¼º¿¡ Âü¿©Çß½À´Ï´Ù.

½É»ç¸¦ °ÅÃÄ Ã¤ÅÃµÈ ¸ðµç ÃÊ·ÏÀÌ ¹Ì±¹ ½ÉÀåÇÐȸÁö(JACC)ÀÇ Áõº¸ÆÇ ¿Â¶óÀÎ Çü½ÄÀ¸·Î ÃâÆǵǾú½À´Ï´Ù.

2015

TCTAP ÇÐȸ°¡ 20ÁÖ³âÀ» ¸ÂÀÌÇß½À´Ï´Ù.

2016

À¯¿ëÇÑ Á¤º¸¿Í ¼ÒÁßÇÑ ¼ø°£µéÀ» °øÀ¯Çϱâ À§Çؼ­ ½ÉÀåÇ÷°ü¿¬±¸Àç´ÜÀÇ °ø½Ä Facebook ÆäÀÌÁö¸¦ ½Å¼³ÇÏ¿´½À´Ï´Ù. ¿Â¶óÀÎÀ» ÅëÇØ Âü°¡ÀÚµéÀÌ °­ÀÇ¿Í ¶óÀÌºê ½Ã¿¬À» ½ÃûÇÒ ¼ö ÀÖµµ·Ï À¥Ä³½ºÆ® ¼­ºñ½º¸¦ ·±ÄªÇÏ¿´½À´Ï´Ù.

2017

ÇÐȸ¸¦ ÅëÇØ CTO, Endovascular, Coronary, Valve¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ Èï¹Ì·Î¿î ÁÖÁ¦µéÀ» ´Ù·ç¾ú½À´Ï´Ù.

Âü°¡ÀÚµéÀÌ ½Ã°ø°£Àû Á¦¾à¾øÀÌ ÀÚ·á¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Æ÷½ºÅÍ ÃÊ·Ï ¼¼¼Ç¿¡ µðÁöÅÐ Çü½ÄÀ» µµÀÔÇÏ¿´½À´Ï´Ù. ¶ÇÇÑ, TCTAP ¿ä¾à ÀÎÅͺ並 À¥Ä³½ºÆ®¸¦ ÅëÇØ ½Ç½Ã°£À¸·Î ½ÃûÇÒ ¼ö ÀÖµµ·Ï ½Ã½ºÅÛÀ» ±¸ÃàÇß½À´Ï´Ù.

2019

Âü¼®Àڵ鿡°Ô ±âÃÊ°­ÀÇ, ½Ç½À±³À° µî ½Ç¹«ÀûÀÎ ÇнÀ ±âȸ¸¦ Á¦°øÇϱâ À§Çؼ­ ÈÄ¿ø»ç¿¡¼­ ¿î¿µÇÏ´Â Æ®·¹ÀÌ´× ÄÚ½º¸¦ È®´ëÇÏ¿´½À´Ï´Ù.

ACT Program 10ÁÖ³âÀ» ±â³äÇϱâ À§ÇÏ¿©, ACT ȨĿ¹Ö ¼¼¼ÇÀÌ ¸¶·ÃµÇ¾ú½À´Ï´Ù.

2020

TCTAPÇÐȸ°¡ Äڷγª ½Ã±¹À¸·Î ÀÎÇØ ´ÜÀýµÈ ±³À° ±âȸ¸¦ Áö¼ÓÀûÀ¸·Î Á¦°øÇϱâ À§ÇØ AP VALVESÇÐȸ¿Í ÅëÇÕÇÏ¿© ¿Â¶óÀÎÀ¸·Î °³ÃֵǾú½À´Ï´Ù.

¿Â¶óÀÎ ÇÐȸÀÇ ´ÜÁ¡ÀÎ ¼ÒÅë ±â´ÉÀÇ ºÎÀ縦 º¸¿ÏÇÏ°íÀÚ ±¹³»¿Ü °¢ºÐ¾ß Àü¹®°¡µéÀ» ¶óÀ̺ê äÆà Åä·ÐÀÚ·Î ÃÊûÇÏ¿© Âü°¡ÀÚµéÀÌ Àû±ØÀûÀ¸·Î Q&A¸¦ ÇÒ ¼ö ÀÖµµ·Ï '¶óÀ̺ê äÆà ¼­ºñ½º'¸¦ Á¦°øÇÏ¿´½À´Ï´Ù.

2021

¿Â¶óÀÎ »óÀÇ ¼ÒÅë °­È­¸¦ À§ÇØ ÆäÀ̽ººÏ, ÀνºÅ¸±×·¥, Æ®À§ÅÍ, À¯Æ©ºê µîÀÇ °ø½Ä ¼Ò¼È³×Æ®¿öÅ©¼­ºñ½º(SNS) ä³ÎÀ» °³Æí ¹× °³¼³Çß½À´Ï´Ù.

±¹³»¿Ü Âü°¡ÀÚµé Áß ¡°Social Media Ambassador¡±À» ¼±Á¤ÇÏ¿© SNS °ø½Ä °èÁ¤¿¡ »çÁø, µ¿¿µ»ó, ÇÏÀ̶óÀÌÆ®, Èï¹Ì·Î¿î ÄÜÅÙÃ÷¸¦ °Ô½ÃÇÏ´Â µî ¿Â¶óÀÎ ¼ÒÅë ¹× Á¤º¸ °øÀ¯ÀÇ ±âȸ¸¦ È®´ëÇÏ¿´½À´Ï´Ù.

2022

°è¼ÓµÇ´Â ¿Â¶óÀÎ ÇÐȸÀÇ Áö·çÇÔÀ» ´ú°í ÃֽŠƮ·»µå¸¦ ¹Ý¿µÇÏ°íÀÚ ¸ÞŸ¹ö½º ÄÁ¼ÁÀ» ȨÆäÀÌÁö¿¡ Á¢¸ñÇØ °ü°´µé¿¡°Ô »õ·Î¿î °æÇèÀ» ¼±»çÇß½À´Ï´Ù. TCTAPÇÐȸ¿¡ ´ëÇÑ Èï¹Ì·Î¿î ÄÜÅÙÃ÷¸¦ Á¦°øÇÏ°í, °ø°£ÀÇ Á¦¾à ¾øÀÌ ¼­·Î ¼ÒÅëÇÒ ¼ö ÀÖ´Â ±â´ÉÀ» Á¦½ÃÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù.

2023

TCTAPÇÐȸ°¡ Áö³­ 3³â°£ÀÇ ¿Â¶óÀÎ ÇÐȸ ÀÌÈÄ ÇÏÀ̺긮µå Çü½ÄÀ¸·Î °³ÃÖµÇ¾î ¿Â¶óÀÎ Âü°¡ÀÚ¿Í ÇöÀå Âü°¡ÀÚ ¸ðµÎ¿¡°Ô »õ·Î¿î ÇüÅÂÀÇ Ä¿¹Â´ÏÄÉÀÌ¼Ç ±âȸ¸¦ Á¦°øÇß½À´Ï´Ù.